SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022284
Filing Date
2020-08-14
Accepted
2020-08-14 16:26:51
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_soligenix.htm 10-Q 549551
2 CERTIFICATION f10q0620ex31-1_soligenix.htm EX-31.1 10226
3 CERTIFICATION f10q0620ex31-2_soligenix.htm EX-31.2 10091
4 CERTIFICATION f10q0620ex32-1_soligenix.htm EX-32.1 3823
5 CERTIFICATION f10q0620ex32-2_soligenix.htm EX-32.2 3755
  Complete submission text file 0001213900-20-022284.txt   3308015

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20200630.xml EX-101.INS 483574
7 XBRL SCHEMA FILE sngx-20200630.xsd EX-101.SCH 50403
8 XBRL CALCULATION FILE sngx-20200630_cal.xml EX-101.CAL 34598
9 XBRL DEFINITION FILE sngx-20200630_def.xml EX-101.DEF 187959
10 XBRL LABEL FILE sngx-20200630_lab.xml EX-101.LAB 392425
11 XBRL PRESENTATION FILE sngx-20200630_pre.xml EX-101.PRE 199189
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 201105528
SIC: 2834 Pharmaceutical Preparations